1) To use evidence from RCTs in providing an estimate of the overall effects of the newer anticonvulsants in improving treatment response and reducing symptom severity in the treatment of anxiety disorders.
2) To determine whether particular anticonvulsants are more effective and tolerable than others in the treatment of anxiety disorders.
3) To determine whether the particular anxiety disorder treated predicts the effectiveness of anticonvulsants in terms of efficacy and tolerability.
4) To identify which factors (clinical, methodological) predict response to pharmacotherapy.
This is a protocol.